Amifer IV

Form: IV injection
Dosage: 20mg
Packaging: 5 ampoules of 5 ml

Active substance:  Elemental iron

Form: ampoules Solution for injection or concentrate for solution for infusion.

Dosage: 100 mg elemental iron per ampule of 5 ml

packaging: Box 5 ampoules.

 

Target: patients suffering from iron deficiency with or without anaemia when oral treatment is not possible or is less effective

Amifer IV is indicated for the treatment of iron deficiency in the following indications:

  • Where there is a clinical need for a rapid iron supply,
  • In patients who cannot tolerate oral iron therapy or who are non-compliant,
  • In active inflammatory bowel disease where oral iron preparations are ineffective,
  • In chronic kidney disease when oral iron preparations are less effective.

Base:  The total cumulative dose of Amifer IV, equivalent to the total iron deficit (mg), is determined by the haemoglobin level (Hb) and body weight (BW). The dose of Amifer IV must be individually calculated for each patient according to the total iron deficit calculated with the following Ganzoni formula

Total amount of Amifer IV (20 mg of iron per ml) to be administered is equivalent to the total Iron deficit (mg) devides by 20 mg/ml

Simplified method

  • Iron deficiency without anemia: 1 IV ampoule each 3 days
  • Iron deficiency with anemia

 

  • Initial hemoglobin value: ≥ 10
    • Body weight < 50 kg
      • => 500 mg
    • Body weight 50 à 70 kg
      • => 1000 mg
    • Body weight 70 kg
      • => 1500 mg
  • Initial hemoglobin value: 7 à 10
    • Body weight < 50 kg
      • => 500 mg
    • Body weight 50 à 70 kg
      • => 1500 mg
    • Body weight 70 kg
      • => 2000 mg
  • Initial hemoglobin value: < 7
    • Body weight < 50 kg
    • Body weight 50 à 70 kg
      • => 2000 mg
    • Body weight 70 kg
      • => 2500 mg

Amifer IV should only be given intravenously.

This may be

– slow intravenous injection (bolus at a rate of 1 ml per minute)

– a drip infusion (diluted only in saline)

– or an injection directly into the venous line of a dialysis machine.

It is recommended not to exceed 200 mg of Amifer IV per day and this 1 to 3 times per week (max 1 day out of 2) ou d’une injection effectuée directement dans la ligne veineuse d’un générateur de dialyse.

Over-the-counter drug

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo (https://www.dafrapharma-vet.com/). In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma